{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:31:09Z","timestamp":1784003469709,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Research Project of Changzhou Medical Center of Nanjing Medical University","award":["CMCB202406"],"award-info":[{"award-number":["CMCB202406"]}]},{"name":"the Jiangsu Provincial Health Commission General Project","award":["MQ2024036"],"award-info":[{"award-number":["MQ2024036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10495-026-02361-8","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:32:52Z","timestamp":1780392772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Succinate drives breast cancer bone metastasis by activating the HIF1\u03b1\/YTHDF1\/YAP signaling axis to upregulate chemokine CXCL5 and disrupt the bone microenvironment"],"prefix":"10.1007","volume":"31","author":[{"given":"Jiao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2361_CR1","doi-asserted-by":"publisher","first-page":"100597","DOI":"10.1016\/j.jbo.2024.100597","volume":"45","author":"J Zarrer","year":"2024","unstructured":"Zarrer J, Taipaleenm\u00e4ki H (2024) The osteoblast in regulation of tumor cell dormancy and bone metastasis. J Bone Oncol 45:100597","journal-title":"J Bone Oncol"},{"key":"2361_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/medicina61020360","volume":"61","author":"\u0130 \u00d6ner","year":"2025","unstructured":"\u00d6ner \u0130, An\u0131k H, Kurt \u0130nci B et al (2025) A comparison of the efficacy and safety of Denosumab and Zoledronic Acid in patients with bone metastatic breast cancer receiving CDK4\/6 inhibitor therapy. Medicina (Kaunas) 61:360","journal-title":"Medicina (Kaunas)"},{"key":"2361_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41416-021-01424-8","volume":"125","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ye F, Liang Y, Yang Q (2021) Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies. Br J Cancer 125:1056\u20131067","journal-title":"Br J Cancer"},{"key":"2361_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jnci.2012.06.002","volume":"24","author":"HA Azim","year":"2012","unstructured":"Azim HA, Kamal NS, Azim HA Jr (2012) Bone metastasis in breast cancer: the story of RANK-Ligand. J Egypt Natl Canc Inst 24:107\u2013114","journal-title":"J Egypt Natl Canc Inst"},{"key":"2361_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40001-023-01083-w","volume":"28","author":"X Chao","year":"2023","unstructured":"Chao X, Zhang Y, Zheng C et al (2023) Metastasis of breast cancer to bones alters the tumor immune microenvironment. Eur J Med Res 28:119","journal-title":"Eur J Med Res"},{"key":"2361_CR6","first-page":"1","volume":"2021","author":"C Liu","year":"2021","unstructured":"Liu C, Wang M, Xu C et al (2021) Immune checkpoint inhibitor therapy for bone metastases: specific microenvironment and current situation. J Immunol Res 2021:1\u201318","journal-title":"J Immunol Res"},{"key":"2361_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12282-023-01491-0","volume":"30","author":"RL Akshaya","year":"2023","unstructured":"Akshaya RL, Saranya I, Selvamurugan N (2023) MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis. Breast Cancer 30:910\u2013925","journal-title":"Breast Cancer"},{"key":"2361_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13578-023-01171-8","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang S, Wu W, Lin X et al (2023) Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions. Cell Biosci 13:224","journal-title":"Cell Biosci"},{"key":"2361_CR9","doi-asserted-by":"publisher","first-page":"e10126","DOI":"10.1002\/jbm4.10126","volume":"3","author":"ME Sowder","year":"2019","unstructured":"Sowder ME, Johnson RW (2019) Bone as a preferential site for metastasis. JBMR Plus 3:e10126","journal-title":"JBMR Plus"},{"key":"2361_CR10","doi-asserted-by":"publisher","first-page":"1435480","DOI":"10.3389\/fonc.2024.1435480","volume":"14","author":"G Pascual","year":"2024","unstructured":"Pascual G, Benitah SA (2024) Lipids in the tumor microenvironment: immune modulation and metastasis. Front Oncol 14:1435480","journal-title":"Front Oncol"},{"key":"2361_CR11","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368:eaaw5473","journal-title":"Science"},{"key":"2361_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3803\/EnM.2020.35.1.36","volume":"35","author":"Y Guo","year":"2020","unstructured":"Guo Y, Cho SW, Saxena D, Li X (2020) Multifaceted actions of Succinate as a signaling transmitter vary with its cellular locations. Endocrinol Metab 35:36\u201343","journal-title":"Endocrinol Metab"},{"key":"2361_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","volume":"77","author":"J-Y Wu","year":"2020","unstructured":"Wu J-Y, Huang T-W, Hsieh Y-T et al (2020) Cancer-derived Succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol Cell 77:213-227.e5","journal-title":"Mol Cell"},{"key":"2361_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/metabo10090372","volume":"10","author":"KJ Harber","year":"2020","unstructured":"Harber KJ, de Goede KE, Verberk SGS et al (2020) Succinate is an inflammation-induced immunoregulatory metabolite in macrophages. Metabolites 10:372","journal-title":"Metabolites"},{"key":"2361_CR15","doi-asserted-by":"publisher","first-page":"0351","DOI":"10.34133\/research.0351","volume":"7","author":"J Wu","year":"2024","unstructured":"Wu J, Liu N, Chen J et al (2024) The tricarboxylic acid cycle metabolites for cancer: friend or enemy. Research 7:0351","journal-title":"Research"},{"key":"2361_CR16","doi-asserted-by":"publisher","first-page":"1404441","DOI":"10.3389\/fimmu.2024.1404441","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, Li G, He Y et al (2024) Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention. Front Immunol 15:1404441","journal-title":"Front Immunol"},{"key":"2361_CR17","doi-asserted-by":"publisher","first-page":"eadr4458","DOI":"10.1126\/scitranslmed.adr4458","volume":"17","author":"S Lu","year":"2025","unstructured":"Lu S, Li J, Li Y et al (2025) Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated macrophage metabolism. Sci Transl Med 17:eadr4458. https:\/\/doi.org\/10.1126\/scitranslmed.adr4458","journal-title":"Sci Transl Med"},{"key":"2361_CR18","doi-asserted-by":"crossref","unstructured":"Basheeruddin M, Qausain S (2024) Hypoxia-inducible factor 1-alpha (HIF-1\u03b1): an essential regulator in cellular metabolic control. Cureus","DOI":"10.7759\/cureus.63852"},{"key":"2361_CR19","doi-asserted-by":"publisher","first-page":"110727","DOI":"10.1016\/j.cellsig.2023.110727","volume":"108","author":"K Cheng","year":"2023","unstructured":"Cheng K, Liu S, Li C et al (2023) IGF2BP3\/HIF1A\/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming. Cell Signal 108:110727","journal-title":"Cell Signal"},{"key":"2361_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li Q, Ni Y, Zhang L et al (2021) HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Sig Transduct Target Ther 6:76","journal-title":"Sig Transduct Target Ther"},{"key":"2361_CR21","doi-asserted-by":"crossref","unstructured":"Basheeruddin M, Qausain S (2024) Hypoxia-inducible factor 1-alpha (HIF-1\u03b1) and cancer: mechanisms of tumor hypoxia and therapeutic targeting. Cureus","DOI":"10.7759\/cureus.70700"},{"key":"2361_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-024-01865-z","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen X, Ma Z, Yi Z et al (2024) The effects of metabolism on the immune microenvironment in colorectal cancer. Cell Death Discov 10:118","journal-title":"Cell Death Discov"},{"key":"2361_CR23","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41388-023-02704-8","volume":"42","author":"X Liu","year":"2023","unstructured":"Liu X, Feng M, Hao X et al (2023) m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1\u03b1 positive feedback loop. Oncogene 42:2047\u20132060","journal-title":"Oncogene"},{"key":"2361_CR24","doi-asserted-by":"publisher","first-page":"112824","DOI":"10.1016\/j.intimp.2024.112824","volume":"140","author":"L Wei","year":"2024","unstructured":"Wei L, Liu S, Xie Z et al (2024) The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression. Int Immunopharmacol 140:112824","journal-title":"Int Immunopharmacol"},{"key":"2361_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-022-04711-1","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao X, Li W, Li L et al (2022) YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell Death Dis 13:258","journal-title":"Cell Death Dis"},{"key":"2361_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41419-020-03315-x","volume":"12","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Yan G, He M et al (2021) ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1\/YAP signaling axis in osteosarcoma. Cell Death Dis 12:60","journal-title":"Cell Death Dis"},{"key":"2361_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","volume":"9","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen J, Ren Y et al (2024) Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Sig Transduct Target Ther 9:270","journal-title":"Sig Transduct Target Ther"},{"key":"2361_CR28","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41467-019-09754-1","volume":"10","author":"M Rossi","year":"2019","unstructured":"Rossi M, Bucci G, Rizzotto D et al (2019) LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-\u03b2. Nat Commun 10:1969","journal-title":"Nat Commun"},{"key":"2361_CR29","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.1038\/s41467-024-54081-9","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Deng F, Zhu W et al (2024) In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy. Nat Commun 15:9723","journal-title":"Nat Commun"},{"key":"2361_CR30","doi-asserted-by":"publisher","first-page":"e22144","DOI":"10.1096\/fj.202100172RR","volume":"36","author":"J Xing","year":"2022","unstructured":"Xing J, He Y, Wang K et al (2022) Involvement of YTHDF1 in renal fibrosis progression via up-regulating YAP. FASEB J 36:e22144","journal-title":"FASEB J"},{"key":"2361_CR31","first-page":"2589","volume":"15","author":"Z Yan","year":"2018","unstructured":"Yan Z, Guo Y, Wang Y et al (2018) MicroRNA profiles of BMSCs induced into osteoblasts with osteoinductive medium. Exp Ther Med 15:2589","journal-title":"Exp Ther Med"},{"key":"2361_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13287-025-04480-6","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Zhao S, Wang H et al (2025) From inflammation to healing: the crucial role of GPR91 activation and SDH inhibition in chronic diabetic wound recovery. Stem Cell Res Ther 16:399","journal-title":"Stem Cell Res Ther"},{"key":"2361_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bph.13738","volume":"174","author":"P Geubelle","year":"2017","unstructured":"Geubelle P, Gilissen J, Dilly S et al (2017) Identification and pharmacological characterization of succinate receptor agonists. Br J Pharmacol 174:796\u2013808","journal-title":"Br J Pharmacol"},{"key":"2361_CR34","doi-asserted-by":"publisher","first-page":"741305","DOI":"10.3389\/fimmu.2021.741305","volume":"12","author":"Z He","year":"2021","unstructured":"He Z, Zhang S (2021) Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment. Front Immunol 12:741305","journal-title":"Front Immunol"},{"key":"2361_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Lu X, Dey P et al (2016) Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov 6:80\u201395","journal-title":"Cancer Discov"},{"key":"2361_CR36","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/ijc.70296","volume":"158","author":"X Yang","year":"2026","unstructured":"Yang X, Kuang H, Sun R et al (2026) The role of CXCL5 in tumor microenvironment: regulatory mechanisms and therapeutic potential. Int J Cancer 158:2023\u20132042. https:\/\/doi.org\/10.1002\/ijc.70296","journal-title":"Int J Cancer"},{"key":"2361_CR37","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","volume":"34","author":"I Elia","year":"2022","unstructured":"Elia I, Rowe JH, Johnson S et al (2022) Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells. Cell Metab 34:1137-1150.e6","journal-title":"Cell Metab"},{"key":"2361_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41589-022-01004-8","volume":"18","author":"MP Murphy","year":"2022","unstructured":"Murphy MP, Chouchani ET (2022) Why succinate? Physiological regulation by a mitochondrial coenzyme Q sentinel. Nat Chem Biol 18:461\u2013469","journal-title":"Nat Chem Biol"},{"key":"2361_CR39","doi-asserted-by":"publisher","first-page":"53819","DOI":"10.18632\/oncotarget.17734","volume":"8","author":"T Zhao","year":"2017","unstructured":"Zhao T, Mu X, You Q (2017) Succinate: an initiator in tumorigenesis and progression. Oncotarget 8:53819\u201353828","journal-title":"Oncotarget"},{"key":"2361_CR40","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.3390\/ijms241311165","volume":"24","author":"KK Wu","year":"2023","unstructured":"Wu KK (2023) Extracellular succinate: a physiological messenger and a pathological trigger. Int J Mol Sci 24:11165","journal-title":"Int J Mol Sci"},{"key":"2361_CR41","doi-asserted-by":"publisher","first-page":"111193","DOI":"10.1016\/j.celrep.2022.111193","volume":"40","author":"N Gudgeon","year":"2022","unstructured":"Gudgeon N, Munford H, Bishop EL et al (2022) Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation. Cell Rep 40:111193","journal-title":"Cell Rep"},{"key":"2361_CR42","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-024-01402-6","volume":"31","author":"L Lanzetti","year":"2024","unstructured":"Lanzetti L (2024) Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer. Cell Death Differ 31:1582\u20131594","journal-title":"Cell Death Differ"},{"key":"2361_CR43","doi-asserted-by":"publisher","first-page":"217076","DOI":"10.1016\/j.canlet.2024.217076","volume":"597","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhao Y, Song H et al (2024) Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications. Cancer Lett 597:217076","journal-title":"Cancer Lett"},{"key":"2361_CR44","doi-asserted-by":"publisher","first-page":"13965","DOI":"10.1074\/jbc.RA120.013820","volume":"295","author":"C Ben","year":"2020","unstructured":"Ben C, Wu X, Takahashi-Kanemitsu A et al (2020) Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1. J Biol Chem 295:13965\u201313980","journal-title":"J Biol Chem"},{"key":"2361_CR45","doi-asserted-by":"publisher","first-page":"215640","DOI":"10.1016\/j.canlet.2022.215640","volume":"537","author":"X Xu","year":"2022","unstructured":"Xu X, Wang B, Liu Y et al (2022) ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma. Cancer Lett 537:215640","journal-title":"Cancer Lett"},{"key":"2361_CR46","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1097\/CM9.0000000000002686","volume":"136","author":"Q Li","year":"2023","unstructured":"Li Q, Ma N, Li X et al (2023) Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. Chin Med J 136:1448\u20131458","journal-title":"Chin Med J"},{"key":"2361_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00262-024-03689-3","volume":"73","author":"Q Lei","year":"2024","unstructured":"Lei Q, Zhen S, Zhang L et al (2024) A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis. Cancer Immunol Immunother 73:108","journal-title":"Cancer Immunol Immunother"},{"key":"2361_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41385-020-0297-3","volume":"14","author":"Y Lin","year":"2021","unstructured":"Lin Y, Cheng L, Liu Y et al (2021) Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitment. Mucosal Immunol 14:187\u2013198","journal-title":"Mucosal Immunol"},{"key":"2361_CR49","doi-asserted-by":"publisher","first-page":"18192","DOI":"10.1074\/jbc.RA119.010018","volume":"294","author":"WK Lim","year":"2019","unstructured":"Lim WK, Chai X, Ghosh S et al (2019) G\u03b1-13 induces CXC motif chemokine ligand 5 expression in prostate cancer cells by transactivating NF-\u03baB. J Biol Chem 294:18192\u201318206","journal-title":"J Biol Chem"},{"key":"2361_CR50","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1038\/s41598-022-07521-9","volume":"12","author":"A Narazaki","year":"2022","unstructured":"Narazaki A, Shimizu R, Yoshihara T et al (2022) Determination of the physiological range of oxygen tension in bone marrow monocytes using two-photon phosphorescence lifetime imaging microscopy. Sci Rep 12:3497","journal-title":"Sci Rep"},{"key":"2361_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC (2020) Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol 21:268\u2013283","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2361_CR52","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00129.2024","volume":"327","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xiu Z, Qu K et al (2024) Trailblazing in adjuvant research: succinate\u2019s uncharted territory with neutrophils. Am J Physiol Cell Physiol 327:C1\u2013C10","journal-title":"Am J Physiol Cell Physiol"},{"key":"2361_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/15384101.2025.2508109","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Wang X, Guo M, Xu H (2025) Succinate reduces biological activity and mitochondrial function of human adipose-derived stem cells. Cell Cycle 24:16\u201328","journal-title":"Cell Cycle"},{"key":"2361_CR54","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2016.217","volume":"36","author":"PF Yu","year":"2016","unstructured":"Yu PF, Huang Y, Han YY et al (2016) TNF\u03b1-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene 36:482\u2013490","journal-title":"Oncogene"},{"key":"2361_CR55","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1158\/0008-5472.CAN-15-0204","volume":"76","author":"AJ Giles","year":"2016","unstructured":"Giles AJ, Reid CM, Evans JD et al (2016) Activation of hematopoietic stem\/progenitor cells promotes immunosuppression within the pre\u2013metastatic niche. Cancer Res 76:1335\u20131347","journal-title":"Cancer Res"},{"key":"2361_CR56","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3390\/cancers13143459","volume":"13","author":"DC Rabe","year":"2021","unstructured":"Rabe DC, Walker ND, Rustandy FD et al (2021) Tumor extracellular vesicles regulate macrophage-driven metastasis through CCL5. Cancers 13:3459","journal-title":"Cancers"},{"key":"2361_CR57","doi-asserted-by":"publisher","first-page":"1223864","DOI":"10.3389\/fimmu.2023.1223864","volume":"14","author":"I Khanduri","year":"2023","unstructured":"Khanduri I, Maru DM, Parra ER (2023) Exploratory study of macrophage polarization and spatial distribution in colorectal cancer liver metastasis: a pilot study. Front Immunol 14:1223864","journal-title":"Front Immunol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02361-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:46:36Z","timestamp":1782852396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02361-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02361-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"20 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Nanjing Medical University (No. [2021] KY203-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"164"}}